These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31095649)

  • 1. Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinoma.
    Sobti A; Sharif-Askari FS; Khan S; Sharif-Askari NS; Hachim MY; Williams L; Zhou Y; Hopper C; Hamoudi R
    PLoS One; 2019; 14(5):e0217000. PubMed ID: 31095649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
    Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
    Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
    Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
    Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
    J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Human Papillomavirus-Associated Head and Neck Cancers in a Veteran Population.
    Shay SG; Chang E; Lewis MS; Wang MB
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):790-6. PubMed ID: 26270931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus-related head and neck tumors: clinical and research implication.
    Psyrri A; Gouveris P; Vermorken JB
    Curr Opin Oncol; 2009 May; 21(3):201-5. PubMed ID: 19370803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.
    Agrawal Y; Koch WM; Xiao W; Westra WH; Trivett AL; Symer DE; Gillison ML
    Clin Cancer Res; 2008 Nov; 14(21):7143-50. PubMed ID: 18981014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral HPV infection and persistence in patients with head and neck cancer.
    Morbini P; Dal Bello B; Alberizzi P; Mannarini L; Mevio N; Garotta M; Mura F; Tinelli C; Bertino G; Benazzo M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Oct; 116(4):474-84. PubMed ID: 24035114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
    Nygård M; Aagnes B; Bray F; Møller B; Mork J
    Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany.
    Quabius ES; Haag J; Kühnel A; Henry H; Hoffmann AS; Görögh T; Hedderich J; Evert M; Beule AG; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Tribius S; Röcken C; Ambrosch P; Hoffmann M
    Int J Oncol; 2015 Jan; 46(1):414-22. PubMed ID: 25310104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.